Joint Formulary & PAD

Macrogol compound - Constipation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Sachets (powder)
Associated Icons :
Restrictions / Comments :
Important
Prescribe as macrogol compound oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
 

Status 2

Red
Formulations :
  • Sachets (powder)
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important
Moviprep / Plenvu - ADULTS only. Off-label use. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Macrogol compound
Indication :
Constipation
Group Name :
Keywords :
laxatives
Brand Names Include :
Laxido, Movicol, Cosmocol, Macilax, Molaxole, Strigol, Moviprep, Plenvu
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (2)

The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.

Management | Constipation | CKS | NICE

The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.

Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.

GENERIC macrogol compound has been considered by the APC and has been assigned a GREEN traffic light status.

NOTE - the branded product, Movicol, was considered NON-FORMULARY at the APC in May 2017